Prevention of local thromboembolic complications during continuous infusion of coagulation factor concentrates: parallel infusion of saline versus heparin and parallel infusion of saline?

Completed

• Conditions: bleeding disorder; Haemophilia; 10005330

• Registration Number: NL-OMON36776
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 42

Inclusion Criteria

- Patients with haemophilia A
- Planned for elective operation
- Getting a continuous infusion of coagulation factor concentrates (FVIII)
- 18 years and older

Exclusion Criteria

Under 18 years
The use of FVIIa (used by patients with inhibitors)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Lifespan of the intravenous catheters in both groups.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>V.I.P. score, a standardised score for thrombophlebitis.</p><br>